Funding for practice-oriented clinical research

P. Rothwell

DOI: https://doi.org/10.1016/S0140-6736(06)69010-7

IF: 202.731

2006-07-22

The Lancet

Abstract:

What problem does this paper attempt to address?

Molecular and Long-Term Behavioral Consequences of Neonatal Opioid Exposure and Withdrawal in Mice.

Amelia D. D. Dunn,Shivon A. A. Robinson,Chiso Nwokafor,Molly Estill,Julia Ferrante,Li Shen,Crystal O. O. Lemchi,Jordi Creus-Muncunill,Angie Ramirez,Juliet Mengaziol,Julia K. K. Brynildsen,Mark Leggas,Jamie Horn,Michelle E. E. Ehrlich,Julie A. A. Blendy

DOI: https://doi.org/10.3389/fnbeh.2023.1202099

IF: 3.617

2023-01-01

Frontiers in Behavioral Neuroscience

Abstract:Introduction:Infants exposed to opioids in utero are at high risk of exhibiting Neonatal Opioid Withdrawal Syndrome (NOWS), a combination of somatic withdrawal symptoms including high pitched crying, sleeplessness, irritability, gastrointestinal distress, and in the worst cases, seizures. The heterogeneity of in utero opioid exposure, particularly exposure to polypharmacy, makes it difficult to investigate the underlying molecular mechanisms that could inform early diagnosis and treatment of NOWS, and challenging to investigate consequences later in life.Methods:To address these issues, we developed a mouse model of NOWS that includes gestational and post-natal morphine exposure that encompasses the developmental equivalent of all three human trimesters and assessed both behavior and transcriptome alterations.Results:Opioid exposure throughout all three human equivalent trimesters delayed developmental milestones and produced acute withdrawal phenotypes in mice reminiscent of those observed in infants. We also uncovered different patterns of gene expression depending on the duration and timing of opioid exposure (3-trimesters, in utero only, or the last trimester equivalent only). Opioid exposure and subsequent withdrawal affected social behavior and sleep in adulthood in a sex-dependent manner but did not affect adult behaviors related to anxiety, depression, or opioid response.Discussion:Despite marked withdrawal and delays in development, long-term deficits in behaviors typically associated with substance use disorders were modest. Remarkably, transcriptomic analysis revealed an enrichment for genes with altered expression in published datasets for Autism Spectrum Disorders, which correlate well with the deficits in social affiliation seen in our model. The number of differentially expressed genes between the NOWS and saline groups varied markedly based on exposure protocol and sex, but common pathways included synapse development, the GABAergic and myelin systems, and mitochondrial function.
The immediate and long-term effects of prenatal opioid exposure

Elizabeth Yen,Jonathan M. Davis

DOI: https://doi.org/10.3389/fped.2022.1039055

IF: 3.569

2022-11-08

Frontiers in Pediatrics

Abstract:The opioid epidemic has adversely affected neonates and children, yet the mechanisms by which it impacts this population are not well understood. Not only does prenatal opioid exposure result in short-term consequences shortly after birth, it also creates long-term sequelae that may predispose these children to physical, emotional, psychiatric, cognitive, and socioeconomic problems in the future. This article provides a scoping overview of the long-term effects of antenatal opioid exposure on neonates and children as well as quality improvement and research efforts to understand and mitigate this major public health concern.

pediatrics
Mitochondrial Genome Maintenance: Roles for Nuclear Nonhomologous End-Joining Proteins in Saccharomyces cerevisiae

Lidza Kalifa,Daniel F Quintana,Laura K Schiraldi,Naina Phadnis,Garry L. Coles,R. A. Sia,E. Sia

DOI: https://doi.org/10.1534/genetics.111.138214

IF: 4.402

2012-03-01

Genetics

Abstract:Mitochondrial DNA (mtDNA) deletions are associated with sporadic and inherited diseases and age-associated neurodegenerative disorders. Approximately 85% of mtDNA deletions identified in humans are flanked by short directly repeated sequences; however, mechanisms by which these deletions arise are unknown. A limitation in deciphering these mechanisms is the essential nature of the mitochondrial genome in most living cells. One exception is budding yeast, which are facultative anaerobes and one of the few organisms for which directed mtDNA manipulation is possible. Using this model system, we have developed a system to simultaneously monitor spontaneous direct-repeat–mediated deletions (DRMDs) in the nuclear and mitochondrial genomes. In addition, the mitochondrial DRMD reporter contains a unique KpnI restriction endonuclease recognition site that is not present in otherwise wild-type (WT) mtDNA. We have expressed KpnI fused to a mitochondrial localization signal to induce a specific mitochondrial double-strand break (mtDSB). Here we report that loss of the MRX (Mre11p, Rad50p, Xrs2p) and Ku70/80 (Ku70p, Ku80p) complexes significantly impacts the rate of spontaneous deletion events in mtDNA, and these proteins contribute to the repair of induced mtDSBs. Furthermore, our data support homologous recombination (HR) as the predominant pathway by which mtDNA deletions arise in yeast, and suggest that the MRX and Ku70/80 complexes are partially redundant in mitochondria.
Phytoalexins: antiparasitics of higher plants.

M. J. O'neill

DOI: https://doi.org/10.1016/0169-4758(86)90059-1

1986-12-01

Parasitology Today

Abstract:
Maternal care behavior and physiology moderate offspring outcomes following gestational exposure to opioids

Abigail M Myers,Scott E Bowen,Susanne Brummelte

DOI: https://doi.org/10.1002/dev.22433

Abstract:The opioid epidemic has resulted in a drastic increase in gestational exposure to opioids. Opioid-dependent pregnant women are typically prescribed medications for opioid use disorders ("MOUD"; e.g., buprenorphine [BUP]) to mitigate the harmful effects of abused opioids. However, the consequences of exposure to synthetic opioids, particularly BUP, during gestation on fetal neurodevelopment and long-term outcomes are poorly understood. Further, despite the known adverse effects of opioids on maternal care, many preclinical and clinical studies investigating the effects of gestational opioid exposure on offspring outcomes fail to report on maternal care behaviors. Considering that offspring outcomes are heavily dependent upon the quality of maternal care, it is important to evaluate the effects of gestational opioid exposure in the context of the mother-infant dyad. This review compares offspring outcomes after prenatal opioid exposure and after reduced maternal care and integrates this information to potentially identify common underlying mechanisms. We explore whether adverse outcomes after gestational BUP exposure are due to direct effects of opioids in utero, deficits in maternal care, or a combination of both factors. Finally, suggestions for improving preclinical models of prenatal opioid exposure are provided to promote more translational studies that can help to improve clinical outcomes for opioid-dependent mothers.
Prenatal exposure to opioids and neurodevelopment in infancy and childhood: A systematic review

Arin A. Balalian,Richard Graeve,Matthias Richter,Astrid Fink,Heike Kielstein,Silvia S. Martins,Morgan M. Philbin,Pam Factor-Litvak

DOI: https://doi.org/10.3389/fped.2023.1071889

IF: 3.569

2023-02-22

Frontiers in Pediatrics

Abstract:Aim: This systematic review aims to estimate the relationship between prenatal exposure to opioids and neurodevelopmental outcomes and examines potential sources of heterogeneity between the studies. Methods: We searched four databases through May 21st, 2022: PubMed, Embase, PsycInfo and the Web of Science according to a specified search strings. Study inclusion criteria include: (1) cohort and case-control peer-reviewed studies published in English; (2) studies comparing neurodevelopmental outcomes among children with prenatal opioid-exposure (prescribed or used non-medically) vs. an unexposed group. Studies investigating fetal alcohol syndrome or a different primary prenatal exposure other than opioids were excluded. Two main performed data extraction using "Covidence" systematic review platform. This systematic review was conducted in accordance with PRISMA guidelines. The Newcastle-Ottawa-Scale was used for quality assessment of the studies. Studies were synthesized based on the type of neurodevelopmental outcome and the instrument used to assess neurodevelopment. Results: Data were extracted from 79 studies. We found significant heterogeneity between studies due to their use of different instruments to explore cognitive skills, motor, and behavioral outcomes among children of different ages. The other sources of heterogeneity included: procedures to assess prenatal exposure to opioids; period of pregnancy in which exposure was assessed; type of opioids assessed (non-medical, medication used for opioid use dis-order, prescribed by health professional), types of co-exposure; source of selection of prenatally exposed study participants and comparison groups; and methods to address lack of comparability between exposed and unexposed groups. Cognitive and motor skills as well as behavior were generally negatively affected by prenatal opioid exposure, but the significant heterogeneity precluded a meta-analysis. Conclusion: We explored sources of heterogeneity in the studies assessing the association between prenatal exposure to opioids and neurodevelopmental outcomes. Sources of heterogeneity included different approaches to participant recruitment as well as exposure and outcome ascertainment methods. Nonetheless, overall negative trends were observed between prenatal opioid exposure and neuro-developmental outcomes.

pediatrics
Opioid exposure in gestation, postnatal adversity, and preschool-age cognitive functioning

Sanjana Ravi,Andrew E. Molnar,Emilia F. Cárdenas,Autumn Kujawa,Kathryn L. Humphreys

DOI: https://doi.org/10.1177/01650254241277787

2024-09-22

International Journal of Behavioral Development

Abstract:International Journal of Behavioral Development, Ahead of Print. Children prenatally exposed to opioids exhibit impairments in cognitive functioning and have an increased likelihood of experiencing other forms of adversity. Given that these other forms of early life adversity are linked to lower levels of cognitive functioning, it is important to determine whether the association between opioid exposure and cognitive functioning is better explained by other forms of adversity. The current study used a practical design (i.e., caregiver report of a preschool-aged child's exposure to opioids during gestation) to examine the associations between prenatal opioid exposure status (i.e., presence or absence of exposure), postnatal adversity, and preschool-age cognitive functioning. Forty-four preschool-age children, 21 with prenatal opioid exposure (20 of whom were adopted) and 23 comparison children, and their caregivers were invited to a laboratory session during which the child completed a neuropsychological assessment battery while caregivers were interviewed about their child and completed questionnaires. Regression analysis was conducted to examine whether prenatal opioid exposure status explained variation in cognitive functioning over and above child adversity. Children with prenatal opioid exposure had lower full-scale IQ scores than comparison children (Cohen's d =−0.86). After accounting for exposure to postnatal adversity, prenatal opioid exposure status explained 6.01% of the variance in full-scale IQ scores. Taken together, our results suggest that the association between prenatal opioid exposure status and cognitive functioning at preschool age is not better explained by postnatal adversity. These findings underscore efforts to reduce opioid use among people who are pregnant or likely to become pregnant.

psychology, developmental
Neurobehavioral Characterization of Perinatal Oxycodone-Exposed Offspring in Early Adolescence

Adrian Flores,Nghi M. Nguyen,Murali Devanaboyina,Samarth Sanketh,Pranavi Athota,Sankarasubramanian Jagadesan,Chittibabu Guda,Sowmya V. Yelamanchili,Gurudutt Pendyala

DOI: https://doi.org/10.1007/s11481-024-10129-7

2024-06-15

Journal of Neuroimmune Pharmacology

Abstract:The opioid epidemic has received considerable attention, but the impact on perinatal opioid-exposed (POE) offspring remains underexplored. This study addresses the emerging public health challenge of understanding and treating POE children. We examined two scenarios using preclinical models: offspring exposed to oxycodone (OXY) in utero (IUO) and acute postnatal OXY (PNO). We hypothesized exposure to OXY during pregnancy primes offspring for neurodevelopmental deficits and severity of deficits is dependent on timing of exposure. Notable findings include reduced head size and brain weight in offspring. Molecular analyses revealed significantly lower levels of inflammasome-specific genes in the prefrontal cortex (PFC). Gene Set Enrichment Analysis (GSEA) and Ingenuity Pathway Analysis (IPA) highlighted the enrichment of genes associated with mitochondrial and synapse dysfunction in POE offspring. Western blot analysis validated IPA predictions of mitochondrial dysfunction in PFC-derived synaptosomes. Behavioral studies identified significant social deficits in POE offspring. This study presents the first comparative analysis of acute PNO- and IUO-offspring during early adolescence finding acute PNO-offspring have considerably greater deficits. The striking difference in deficit severity in acute PNO-offspring suggests that exposure to opioids in late pregnancy pose the greatest risk for offspring well-being.

pharmacology & pharmacy,neurosciences
Preconception opioids interact with mouse strain to alter morphine withdrawal in the next generation

Anika Toorie,Claire Davidson Hall,Fair M. Vassoler,Gary Peltz,Elizabeth M. Byrnes

DOI: https://doi.org/10.1007/s00213-024-06574-0

2024-03-21

Psychopharmacology

Abstract:Transgenerational effects of preconception morphine exposure in female rats have been reported which suggest that epigenetic modifications triggered by female opioid exposure, even when that exposure ends several weeks prior to pregnancy, has significant ramifications for their future offspring.

pharmacology & pharmacy,neurosciences,psychiatry
The effects of prenatal exposure to opioids on early childhood development: context matters most

Ginny Carter,Sarah McGlothlin,Skye McLaurin-Jiang,Rebecca B. Carlson,Kevin E. O’Grady,Hendree E. Jones

DOI: https://doi.org/10.1080/14656566.2024.2365331

2024-06-15

Expert Opinion on Pharmacotherapy

Abstract:Introduction The opioid crisis has brought an increasing focus on the long-term outcomes of children following prenatal opioid exposure. Evidence to date has been conflicting, which has caused confusion and concern amongst parents, caregivers, social service providers, medical providers and policy makers.

pharmacology & pharmacy
A review of the literature: How does prenatal opioid exposure impact placental health and fetal brain development?

Audrey Humphries,Kim Simcox,Brittany Howell

DOI: https://doi.org/10.1002/dev.22378

2023-03-04

Developmental Psychobiology

Abstract:In recent years, there has been a sixfold increase in the number of pregnant people with opioid use disorder (OUD). Rates of neonatal opioid withdrawal syndrome (NOWS), previously known as neonatal abstinence syndrome (NAS), have significantly increased in virtually every state and demographic group (Healthcare Cost Utilization Project, HCUP, 2010). NOWS is a condition resulting from chronic exposure to either therapeutic opioid use (e.g., medication for OUD, chronic pain conditions) or nonprescribed opioid use. To date, there is no known prenatal treatment to help decrease the risk of infants developing NOWS and subsequent neurodevelopmental outcomes. Given the increasing support for how placental signaling, or placental programming, may play a role in downstream pathology, prospective research investigating how the placenta is affected by chronic opioid exposure morphologically, histologically, and at the cellular level may open up potential treatment opportunities in this field. In this review, we discuss literature exploring the physiological roles of nitric oxide and dopamine not only in the vascular development of the placenta, but also in fetal cerebral blood flow, neurogenesis, neuronal differentiation, and neuronal activity. We also discuss histological preclinical studies that suggest chronic opioid exposure to induce some combination of placental dysfunction and hypoxia in a manner similar to other well‐known placental pathologies, as denoted by the compensatory neovascularization and increased utilization of the placenta's supply of trophoblast cells, which play an essential role in placental angiogenesis. Overall, we found that the current literature, while limited, suggests chronic opioid exposure negatively impacts placental function and fetal brain development on a cellular and histopathological level. We conclude that it is worthwhile to consider the placenta as a therapeutic target with the ultimate goal of decreasing the incidence of NOWS and the long‐term impacts of prenatal opioid exposure.

psychology,developmental biology
Brain Metabolism, “Ferrin,” and Non‐Carbohydrate Oxidation

B. Libet

DOI: https://doi.org/10.1096/fasebj.7.6.8472897

1993-04-01

The FASEB Journal

Abstract:K.A.C. Elliott and I submitted a paper (1) to the 1943 Federation Meeting in Cleveland, subsequently cancelled because of wartime exigencies. It was one of a series of studies of brain metabolism by Elliott, Libet, and McNair Scott in the early b940s. I was then a young postdoctoral physiologist with Elliott at the Institute of the Pennsylvania Hospital, before he went to McGill University to spend the next 30-44) years of his distinguished career as a neurochemist. After some war-related research on clothing and survival problems I resumed (in 1945) my primary interests in neuroand electrophysiology (begun earlier with R. W. Gerard); but my time with Elliott gave me invaluable experience in neurochemistry and in rigorous, carefully controlled experimentation. We had demonstrated that homogenized suspensions of rat brain in isotonic media respired at rates comparable to those of brain slices (2). That led to the use of such suspensions for quantitative studies of the oxidation of endogenous and added substrates by brain tissue (3). Among other things, additon of glucose or pyruvate largely suppressed the oxidation of endogenous non-carbohydrate substrates. In theabsence of added glucose, noncarbohydrate oxidation supported respiratory rates at about 50% those with glucose; even these rates fell off sharply after the first 1-2 hours, presumably as available substrate was depleted or as some inhibitory end product accumulated. Added glycogen also stimulated brain respiration, but later on we found that more purified glycogen did not do this and pointed to an impurity asthe agent. That impurity turned out to be iron,in a form bound to a protein obtainable from liver(4).We named it “ferrin.” In a partially purified form it contained b5 % of iron soluble at neutral or even alkaline pH. Ferrin differed from femtin (5) in its absence from horse spleen (the richest source of ferritin) and in certain solubility characteristics. Ido not know whether a physiological role for ferrin was ever established, but it seemed to have potential interest asa form of soluble liver iron and even as a contaminant in certain liver products (as we found with glycogen). The substrates and catalysts in noncarbohydrate oxidation by brain tissue were of considerable interest, especially for events during hypoglycemic shock and seizures induced by insulin. Panimon et al. (6) had reported that iron salts increased the rateof oxygen uptake by brain and other tissues, probably via the oxidation of phospholipids and proteins. We then found that the combined addition of very small amounts of iron and ascorbic acid (b mM) produced a large increase in oxygen uptake by isotonic brain (or liver) suspensions (b, 7). This was accompanied by no change in CO2 evolution. With purified mixed phospholipid from brain or liver, ascorbic acid plus iron compounds produced a very rapid oxidation. Only the cephalic fraction of brain phospholipd was oxidized. Ascorbate or iron alone were only weakly active; other reducing agents could not replace ascorbate; inorganic iron salts were as effective as ferrim, but the latter had the advantage of being soluble at body pH values. Epinephrine inhibited the effectsof iron and ascorbic acid, while certain amino acids facilitated them. All this led to the speculative possibility that iron-protein compounds together with ascorbate may have a role in normal phospholipid metabolism and could thereby affect membrane permeability characteristics. The additional finding, that the oxygen uptake by /ypotonic brain suspensions was greatly stimulated by iron plus ascorbate so as to rise to values almost equal to that of isotonic suspensions, seemed to support the notion of membrane-phospholipid oxidation. That is, disruption of membranes of the cells and their subcellular structures by the hypotonic medium would make such phospholipid-contasning structures more accessible to the iron-ascorbate action. It was also interesting that this action was heat-resistant and did not require the enzymatic catalyses that mediate carbohydrate oxidation (see also ref 6). If
The effects of parental opioid use on the parent–child relationship and children’s developmental and behavioral outcomes: a systematic review of published reports

Magdalena Romanowicz,Jennifer L. Vande Voort,Julia Shekunov,Tyler S. Oesterle,Nuria J. Thusius,Teresa A. Rummans,Paul E. Croarkin,Victor M. Karpyak,Brian A. Lynch,Kathryn M. Schak

DOI: https://doi.org/10.1186/s13034-019-0266-3

2019-01-12

Child and Adolescent Psychiatry and Mental Health

Abstract:BackgroundBetween 2009 and 2014, nearly 3% of US children (age ≤ 17 years) lived in households with at least 1 parent with substance use disorder. The present systematic review aimed to evaluate effects of parental opioid use disorder on the parent–child relationship and child developmental and behavioral outcomes.MethodsSeveral databases were comprehensively searched for studies published from January 1980 through February 2018 that reviewed effects of parental opioid addiction on parent–child relationships and outcomes of children (age, 0–16 years).ResultsOf 304 unique studies, 12 evaluated effects of parental opioid addiction on the parent–child relationship as the primary outcome and on children’s outcomes, including behaviors and development. Observation of mother–child interaction showed that mothers with opioid use disorders are more irritable, ambivalent, and disinterested while showing greater difficulty interpreting children’s cues compared with the control group. Children of parents with opioid use disorders showed greater disorganized attachment; they were less likely to seek contact and more avoidant than children in the control group. The children also had increased risk of emotional and behavioral issues, poor academic performance, and poor social skills. Younger children had increased risk of abuse or neglect, or both, that later in life may lead to such difficulties as unemployment, legal issues, and substance abuse.ConclusionsCurrent evidence shows association between parental opioid addiction and poorer mother–child attachment and suboptimal child developmental and behavioral outcomes. Further research and treatment targeting children and families with parental opioid use are needed to prevent difficulties later in life.

pediatrics,psychiatry
Investigating the neurobiology of maternal opioid use disorder and prenatal opioid exposure using brain organoid technology

Ila Dwivedi,Gabriel G. Haddad

DOI: https://doi.org/10.3389/fncel.2024.1403326

2024-05-16

Frontiers in Cellular Neuroscience

Abstract:Over the past two decades, Opioid Use Disorder (OUD) among pregnant women has become a major global public health concern. OUD has been characterized as a problematic pattern of opioid use despite adverse physical, psychological, behavioral, and or social consequences. Due to the relapsing–remitting nature of this disorder, pregnant mothers are chronically exposed to exogenous opioids, resulting in adverse neurological and neuropsychiatric outcomes. Collateral fetal exposure to opioids also precipitates severe neurodevelopmental and neurocognitive sequelae. At present, much of what is known regarding the neurobiological consequences of OUD and prenatal opioid exposure (POE) has been derived from preclinical studies in animal models and postnatal or postmortem investigations in humans. However, species-specific differences in brain development, variations in subject age/health/background, and disparities in sample collection or storage have complicated the interpretation of findings produced by these explorations. The ethical or logistical inaccessibility of human fetal brain tissue has also limited direct examinations of prenatal drug effects. To circumvent these confounding factors, recent groups have begun employing induced pluripotent stem cell (iPSC)-derived brain organoid technology, which provides access to key aspects of cellular and molecular brain development, structure, and function in vitro . In this review, we endeavor to encapsulate the advancements in brain organoid culture that have enabled scientists to model and dissect the neural underpinnings and effects of OUD and POE. We hope not only to emphasize the utility of brain organoids for investigating these conditions, but also to highlight opportunities for further technical and conceptual progress. Although the application of brain organoids to this critical field of research is still in its nascent stages, understanding the neurobiology of OUD and POE via this modality will provide critical insights for improving maternal and fetal outcomes.

neurosciences
Exposure to drugs of abuse induce effects that persist across generations

Annalisa M Baratta,Richa S Rathod,Sonja L Plasil,Amit Seth,Gregg E Homanics

DOI: https://doi.org/10.1016/bs.irn.2020.08.003

Abstract:Substance use disorders are highly prevalent and continue to be one of the leading causes of disability in the world. Notably, not all people who use addictive drugs develop a substance use disorder. Although substance use disorders are highly heritable, patterns of inheritance cannot be explained purely by Mendelian genetic mechanisms. Vulnerability to developing drug addiction depends on the interplay between genetics and environment. Additionally, evidence from the past decade has pointed to the role of epigenetic inheritance in drug addiction. This emerging field focuses on how environmental perturbations, including exposure to addictive drugs, induce epigenetic modifications that are transmitted to the embryo at fertilization and modify developmental gene expression programs to ultimately impact subsequent generations. This chapter highlights intergenerational and transgenerational phenotypes in offspring following a history of parental drug exposure. Special attention is paid to parental preconception exposure studies of five drugs of abuse (alcohol, cocaine, nicotine, cannabinoids, and opiates) and associated behavioral and physiological outcomes in offspring. The highlighted studies demonstrate that parental exposure to drugs of abuse has enduring effects that persist into subsequent generations. Understanding the contribution of epigenetic inheritance in drug addiction may provide clues for better treatments and therapies for substance use disorders.
Prenatal methadone exposure and child developmental outcomes in 2-year-old children

Terri A Levine,Alison Davie-Gray,Hyun Min Kim,Samantha J Lee,Lianne J Woodward

DOI: https://doi.org/10.1111/dmcn.14808

Abstract:Aim: To examine the developmental outcomes of children born to opioid-dependent females enrolled in methadone maintenance and identify pre- and postnatal factors that place these children at developmental risk. Method: Ninety-nine methadone-maintained females and their 100 infants (42 females, 58 males, mean gestational age 38.8wks) were recruited during pregnancy/at birth and studied to age 2 years alongside a regionally representative comparison group of 108 non-methadone-maintained females and their 110 infants (62 females, 48 males, mean gestational age 39.2wks). Information about perinatal exposure was collected from medical records, maternal urine and infant meconium toxicological analysis, maternal interviews (at birth and at 18mo), and a home visit (at 18mo). At age 2 years, child neuromotor function, cognition, language, and emotional/behavioral dysregulation were assessed. Results: Opioid-exposed children achieved lower motor, cognitive, and language scores and had poorer self, emotional, eating/feeding, and sensory processing regulation than unexposed children. After adjustment for maternal education and other substance use in pregnancy, between-group differences in child motor, cognitive, and overall dysregulation remained. Postnatal parental and family factors explained a further 40% to 52% of between-group differences in child outcomes. Interpretation: These children and families are extremely high-risk and need antenatal and postnatal support. Children exposed to opioids during pregnancy have pervasive developmental difficulties by age 2 years. These challenges are largely explained by adverse pregnancy and socio-environmental exposures, emphasizing the importance of specialist prenatal care and postnatal intervention support. What this paper adds Children born to opioid-dependent females are at high risk of pervasive developmental problems. These problems span a range of functional domains, including motor, cognitive, language, and behavioral/emotional dysregulation. Contributing factors include other adverse pregnancy exposures, postnatal environmental factors, and the direct effects of prenatal opioid exposure.
Multigenerational and transgenerational effects of paternal exposure to drugs of abuse on behavioral and neural function

Lisa R. Goldberg,Thomas J. Gould

DOI: https://doi.org/10.1111/ejn.14060

IF: 3.698

2018-07-20

European Journal of Neuroscience

Abstract:Addictions are highly heritable disorders, with heritability estimates ranging from 39% to 72%. Multiple studies suggest a link between paternal drug abuse and addiction in their children. However, patterns of inheritance cannot be explained purely by Mendelian genetic mechanisms. Exposure to drugs of abuse results in epigenetic changes that may be passed on through the germline. This mechanism of epigenetic transgenerational inheritance may provide a link between paternal drug exposure and addiction susceptibility in the offspring. Recent studies have begun to investigate the effect of paternal drug exposure on behavioral and neurobiological phenotypes in offspring of drug-exposed fathers in rodent models. This review aims to discuss behavioral and neural effects of paternal exposure to alcohol, cocaine, opioids, and nicotine. Although a special focus will be on addiction-relevant behaviors, additional behavioral effects including cognition, anxiety, and depressive-like behaviors will be discussed.

neurosciences
Prenatal heroin exposure alters brain morphology and connectivity in adolescent mice

Kathryn J Hornburg,Lauren M Slosky,Gary Cofer,James Cook,Yi Qi,Fiona Porkka,Nicholas B Clark,Andrea Pires,Jeffrey R Petrella,Leonard E White,William C Wetsel,Lawrence Barak,Marc G Caron,G Allan Johnson

DOI: https://doi.org/10.1002/nbm.4842

Abstract:The United States is experiencing a dramatic increase in maternal opioid misuse and, consequently, the number of individuals exposed to opioids in utero. Prenatal opioid exposure has both acute and long-lasting effects on health and wellbeing. Effects on the brain, often identified at school age, manifest as cognitive impairment, attention deficit, and reduced scholastic achievement. The neurobiological basis for these effects is poorly understood. Here, we examine how in utero exposure to heroin affects brain development into early adolescence in a mouse model. Pregnant C57BL/6J mice received escalating doses of heroin twice daily on gestational days 4-18. The brains of offspring were assessed on postnatal day 28 using 9.4 T diffusion MRI of postmortem specimens at 36 μm resolution. Whole-brain volumes and the volumes of 166 bilateral regions were compared between heroin-exposed and control offspring. We identified a reduction in whole-brain volume in heroin-exposed offspring and heroin-associated volume changes in 29 regions after standardizing for whole-brain volume. Regions with bilaterally reduced standardized volumes in heroin-exposed offspring relative to controls include the ectorhinal and insular cortices. Regions with bilaterally increased standardized volumes in heroin-exposed offspring relative to controls include the periaqueductal gray, septal region, striatum, and hypothalamus. Leveraging microscopic resolution diffusion tensor imaging and precise regional parcellation, we generated whole-brain structural MRI diffusion connectomes. Using a dimension reduction approach with multivariate analysis of variance to assess group differences in the connectome, we found that in utero heroin exposure altered structure-based connectivity of the left septal region and the region that acts as a hub for limbic regulatory actions. Consistent with clinical evidence, our findings suggest that prenatal opioid exposure may have effects on brain morphology, connectivity, and, consequently, function that persist into adolescence. This work expands our understanding of the risks associated with opioid misuse during pregnancy and identifies biomarkers that may facilitate diagnosis and treatment.
Cognitive and Motor Outcomes of Children With Prenatal Opioid Exposure

Su Lynn Yeoh,John Eastwood,Ian M. Wright,Rachael Morton,Edward Melhuish,Meredith Ward,Ju Lee Oei

DOI: https://doi.org/10.1001/jamanetworkopen.2019.7025

2019-07-12

JAMA Network Open

Abstract:Importance: Prenatal opioid exposure (POE) is one of the fastest-growing global health problems, but its association with long-term neurologic and physical development remains unknown.Objective: To assess the association between POE and cognitive and motor development in children from age 6 months to 18 years.Data Sources: Key search terms included prenatal opioid exposure, neonatal abstinence syndrome, and neurocognitive development. Studies were searched using PubMed and Embase, with no publication date restriction, through August 20, 2018.Study Selection: Only published cohort studies comparing the results of age-appropriate standardized cognitive and/or motor tests between children with any POE (aged 0-18 years) with drug-free controls were included. Data that were not convertible to means and SDs were excluded.Data Extraction and Synthesis: This study was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) and Meta-analysis of Observational Studies in Epidemiology (MOOSE) guidelines. Data were pooled using a random-effects model.Main Outcomes and Measures: Standardized mean difference of cognitive and motor tests between POE and nonexposed children.Results: Twenty-six peer-reviewed cohort studies were included. Cognitive outcomes were compared for a total of 1455 children with POE and 2982 nonexposed children across 3 age groups (mean [SE] age at cognitive testing was 13 [1.58] months for the toddler group; 4.5 [0.38] years for the preschool group; and 13 [2.36] years for the school-aged group). Motor outcomes were compared for 688 children with POE and 1500 nonexposed children up to age 6 years (mean [SD] age at motor testing, 2 [0.45] years). Standardized mean difference was lower in cognitive tests for children with POE at 0 to 2 years (d = -0.52; 95% CI, -0.74 to -0.31; P < .001) and 3 to 6 years (d = -0.38; 95% CI, -0.69 to -0.07; P < .001); the difference was not significant for those aged 7 to 18 years (d = -0.44; 95% CI, -1.16 to 0.28; P = .23). Motor scores were lower in children with POE (d = 0.49; 95% CI, 0.23-0.74; P < .001).Conclusions and Relevance: Prenatal opioid exposure appeared to be negatively associated with neurocognitive and physical development from age 6 months, and this association persisted until adolescence. The cause and association of this with POE or other factors (eg, withdrawal treatment) are uncertain but suggest that POE necessitates long-term support and intervention.

medicine, general & internal
Health outcomes in children with prenatal opioid exposure with and without neonatal abstinence syndrome in the first seven years of life: An observational cohort study

Joshua Lambert,Sara Arter,Henry Duah,Teenu Xavier,Jon E. Sprague

DOI: https://doi.org/10.1111/jnu.13000

2024-06-23

Journal of Nursing Scholarship

Abstract:Introduction Prenatal opioid exposure (POE) is a major public health consequence of the opioid epidemic. Long‐term health outcomes associated with POE remain unclear, especially for children with POE without a diagnosis of neonatal abstinence syndrome (NAS). Here, we aimed to describe the health outcomes of children with POE and with POE and NAS compared to unexposed children during the first 7 years of life. Design In this retrospective observational cohort study, children born between 2015 and 2022 were identified from the Maternal and Infant Data Hub (MIDH), a data repository that continuously integrates maternal, neonatal, and pediatric records from two academic medical centers and one pediatric hospital system in the Midwest, USA. Methods International Classification of Diseases, 10th Revision, Clinical Modification (ICD‐10 CM) chapters A00‐N99 served as outcomes of interest. Annual incidence and crude incidence rate ratios were calculated to explore descriptive differences between the exposed and unexposed groups. Results The study included 22,002 children, 20,130 (91.5%) of whom were unexposed and 1872 (8.5%) were exposed. Of the 1872 exposed children, 371 (19.8%) received a diagnosis of NAS (POE + NAS) and 1501 were in the POE‐NAS group. Across all 7 years, exposed children had a higher incidence of diagnoses in most ICD‐10 CM chapters compared to unexposed children. A consistently higher incidence rate ratio of diagnosis was observed in both POE‐NAS and POE + NAS groups (vs. unexposed) related to mental and behavioral disorders, eye diagnoses, and diseases of the musculoskeletal system and gastrointestinal systems. Conclusions POE is associated with an increased risk of diagnoses in a number of ICD‐10 CM chapters throughout childhood. These findings underscore the need for early screening and targeted interventions to support exposed children and improve their well‐being. Further research is required to explore underlying mechanisms and develop preventive measures for at‐risk populations. Clinical Relevance Understanding the conditions more often diagnosed in children with prenatal opioid exposure will help to improve care provided to this population. As a result of study findings, nurses who provide care to children with prenatal opioid exposure can prioritize their assessments and allocate time, resources, and education toward areas more likely to be affected.

nursing

Funding for practice-oriented clinical research

Molecular and Long-Term Behavioral Consequences of Neonatal Opioid Exposure and Withdrawal in Mice.

The immediate and long-term effects of prenatal opioid exposure

Mitochondrial Genome Maintenance: Roles for Nuclear Nonhomologous End-Joining Proteins in Saccharomyces cerevisiae

Phytoalexins: antiparasitics of higher plants.

Maternal care behavior and physiology moderate offspring outcomes following gestational exposure to opioids

Prenatal exposure to opioids and neurodevelopment in infancy and childhood: A systematic review

Opioid exposure in gestation, postnatal adversity, and preschool-age cognitive functioning

Neurobehavioral Characterization of Perinatal Oxycodone-Exposed Offspring in Early Adolescence

Preconception opioids interact with mouse strain to alter morphine withdrawal in the next generation

The effects of prenatal exposure to opioids on early childhood development: context matters most

A review of the literature: How does prenatal opioid exposure impact placental health and fetal brain development?

Brain Metabolism, “Ferrin,” and Non‐Carbohydrate Oxidation

The effects of parental opioid use on the parent–child relationship and children’s developmental and behavioral outcomes: a systematic review of published reports

Investigating the neurobiology of maternal opioid use disorder and prenatal opioid exposure using brain organoid technology

Exposure to drugs of abuse induce effects that persist across generations

Prenatal methadone exposure and child developmental outcomes in 2-year-old children

Multigenerational and transgenerational effects of paternal exposure to drugs of abuse on behavioral and neural function

Prenatal heroin exposure alters brain morphology and connectivity in adolescent mice

Cognitive and Motor Outcomes of Children With Prenatal Opioid Exposure

Health outcomes in children with prenatal opioid exposure with and without neonatal abstinence syndrome in the first seven years of life: An observational cohort study